BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 21787226)

  • 1. Unraveling the ties between celiac disease and intestinal microbiota.
    Sanz Y; De Pama G; Laparra M
    Int Rev Immunol; 2011 Aug; 30(4):207-18. PubMed ID: 21787226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal Microbiota and Celiac Disease: Cause, Consequence or Co-Evolution?
    Cenit MC; Olivares M; Codoñer-Franch P; Sanz Y
    Nutrients; 2015 Aug; 7(8):6900-23. PubMed ID: 26287240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune development and intestinal microbiota in celiac disease.
    Pozo-Rubio T; Olivares M; Nova E; De Palma G; Mujico JR; Ferrer MD; Marcos A; Sanz Y
    Clin Dev Immunol; 2012; 2012():654143. PubMed ID: 23008734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Gut Microbiota in Celiac Disease and probiotics.
    Chibbar R; Dieleman LA
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31590358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The intestinal microbiota and inflammatory bowel disease].
    Guarner F
    Gastroenterol Hepatol; 2011 Mar; 34(3):147-54. PubMed ID: 21377761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pivotal Advance: Bifidobacteria and Gram-negative bacteria differentially influence immune responses in the proinflammatory milieu of celiac disease.
    De Palma G; Cinova J; Stepankova R; Tuckova L; Sanz Y
    J Leukoc Biol; 2010 May; 87(5):765-78. PubMed ID: 20007908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysbiosis a risk factor for celiac disease.
    Girbovan A; Sur G; Samasca G; Lupan I
    Med Microbiol Immunol; 2017 Apr; 206(2):83-91. PubMed ID: 28204873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary Gluten as a Conditioning Factor of the Gut Microbiota in Celiac Disease.
    Bascuñán KA; Araya M; Roncoroni L; Doneda L; Elli L
    Adv Nutr; 2020 Jan; 11(1):160-174. PubMed ID: 31399743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for bacteria in celiac disease?
    Sollid LM; Gray GM
    Am J Gastroenterol; 2004 May; 99(5):905-6. PubMed ID: 15128358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The microbiome as a possible target to prevent celiac disease.
    Leonard MM; Fasano A
    Expert Rev Gastroenterol Hepatol; 2016; 10(5):555-6. PubMed ID: 26999627
    [No Abstract]   [Full Text] [Related]  

  • 11. Double-blind, randomised, placebo-controlled intervention trial to evaluate the effects of Bifidobacterium longum CECT 7347 in children with newly diagnosed coeliac disease.
    Olivares M; Castillejo G; Varea V; Sanz Y
    Br J Nutr; 2014 Jul; 112(1):30-40. PubMed ID: 24774670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of probiotic Enterococcus faecium strain L5 on the microbiota and cytokines expression in rats with dysbiosis induced by antibiotics.
    Tarasova E; Yermolenko E; Donets V; Sundukova Z; Bochkareva A; Borshev I; Suvorova M; Ilyasov I; Simanenkov V; Suvorov AN
    Benef Microbes; 2010 Sep; 1(3):265-70. PubMed ID: 21831763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota and Celiac Disease.
    Marasco G; Di Biase AR; Schiumerini R; Eusebi LH; Iughetti L; Ravaioli F; Scaioli E; Colecchia A; Festi D
    Dig Dis Sci; 2016 Jun; 61(6):1461-72. PubMed ID: 26725064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celiac disease: from gluten to autoimmunity.
    Briani C; Samaroo D; Alaedini A
    Autoimmun Rev; 2008 Sep; 7(8):644-50. PubMed ID: 18589004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response of non-pathogenic gram(+) and gram(-) bacteria in inductive sites of the intestinal mucosa study of the pathway of signaling involved.
    Dogi CA; Weill F; Perdigón G
    Immunobiology; 2010; 215(1):60-9. PubMed ID: 19250703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal microbiota and probiotics in celiac disease.
    de Sousa Moraes LF; Grzeskowiak LM; de Sales Teixeira TF; Gouveia Peluzio Mdo C
    Clin Microbiol Rev; 2014 Jul; 27(3):482-9. PubMed ID: 24982318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celiac disease: from pathogenesis to novel therapies.
    Schuppan D; Junker Y; Barisani D
    Gastroenterology; 2009 Dec; 137(6):1912-33. PubMed ID: 19766641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.
    Tlaskalová-Hogenová H; Stepánková R; Hudcovic T; Tucková L; Cukrowska B; Lodinová-Zádníková R; Kozáková H; Rossmann P; Bártová J; Sokol D; Funda DP; Borovská D; Reháková Z; Sinkora J; Hofman J; Drastich P; Kokesová A
    Immunol Lett; 2004 May; 93(2-3):97-108. PubMed ID: 15158604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into the impact of the intestinal microbiota on health and disease: a symposium report.
    Thomas LV; Ockhuizen T
    Br J Nutr; 2012 Jan; 107 Suppl 1():S1-13. PubMed ID: 22260731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Interaction among Microbiota, Immunity, and Genetic and Dietary Factors Is the Condicio Sine Qua Non Celiac Disease Can Develop.
    Pagliari D; Urgesi R; Frosali S; Riccioni ME; Newton EE; Landolfi R; Pandolfi F; Cianci R
    J Immunol Res; 2015; 2015():123653. PubMed ID: 26090475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.